Topic List : Immunology
Drug combo effective against dengue, Ebola
To develop a potential antiviral treatment, Stanford researchers adopted an unusual approach: Rather than trying to disable viral enzymes, they targeted proteins the infected individual makes — and the virus needs.
Tumor rejection requires coordinated immune response
Effective anti-tumor activity requires a systemic, rather than only a local, immune response at the tumor site. A Stanford study may help clinicians pinpoint why only some cancer patients respond to immunotherapies.
Toxic brain cells may drive neurologic disease
Astrocytes, star-shaped cells in the central nervous system, are essential to the survival and healthy function of brain neurons. But aberrant astrocytes may be driving neurodegenerative disorders.
Inflammatory link to heart disease, death
A chronic inflammatory process that occurs in some, but not all, older people may trigger cardiovascular problems, a new Stanford study shows. Part of the solution might be found in a cup of coffee.
Gene activity foretells autoimmune disease
Stanford researchers and their collaborators have found a way to tell whether patients with systemic sclerosis were improving during drug treatment a year before a standard clinical test could.
New blood test may predict cardiovascular disease
An assessment blending several measures of immune-cell responsiveness predicted cardiovascular problems in individuals who likely would have slipped under the radar.
Podcast: Inside the world of microbiota
Justin Sonnenburg, PhD, an associate professor of microbiology and immunology at Stanford, discusses how the world of microbes and bacteria interplay with human health.
ITI calls for grant applications
Preference will be given to grant applications that are interdisciplinary and that have a disease focus.
Test could greatly reduce antibiotic use
A simple blood test in development could accurately identify which patients need antibiotics, Stanford researchers say.
Insight into bacterial resilience, antibiotic targets
A study by researchers at Stanford and UCSF has generated a new understanding of the fundamental gene networks that make bacteria so resilient to environmental stress and, increasingly, to antibacterial drugs.